Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Pfw9ylb86h, Chembl5314913, Schembl24780932, 2706637-43-4, Ex-a8485, Hy-160023
Molecular Formula
C32H35F6N7O3
Molecular Weight
679.7  g/mol
InChI Key
JOLORSRKBHXPFT-PNGHJTAWSA-N
FDA UNII
PFW9YLB86H

KRAS G12C Inhibitor D3S-001 is an orally bioavailable inhibitor of the oncogenic KRAS substitution mutation G12C, with potential antineoplastic activity. Upon oral administration, KRAS G12C inhibitor D3S-001 selectively targets the KRAS G12C mutant and inhibits KRAS G12C-mediated signaling. This may halt proliferation and metastasis in susceptible tumor cells. KRAS, a member of the RAS family of oncogenes, serves an important role in cell signaling, division and differentiation. Mutations of KRAS may induce constitutive signal transduction leading to tumor cell proliferation, invasion, and metastasis.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[(2S)-4-[(7S)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2R,8S)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile
2.1.2 InChI
InChI=1S/C32H35F6N7O3/c1-17-10-22(40)27(35)25(26(17)32(36,37)38)24-11-23-21(15-47-24)28(43-8-9-45(29(46)18(2)33)20(14-43)4-6-39)42-30(41-23)48-16-31-5-3-7-44(31)13-19(34)12-31/h10,19-20,24H,2-5,7-9,11-16,40H2,1H3/t19-,20+,24+,31+/m1/s1
2.1.3 InChI Key
JOLORSRKBHXPFT-PNGHJTAWSA-N
2.2 Other Identifiers
2.2.1 UNII
PFW9YLB86H
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Pfw9ylb86h

2. Chembl5314913

3. Schembl24780932

4. 2706637-43-4

5. Ex-a8485

6. Hy-160023

7. 2-((s)-4-((s)-7-(3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl)-2-(((2r,7as)-2-fluorotetrahydro-1h-pyrrolizin-7a(5h)-yl)methoxy)-7,8-dihydro-5h-pyrano[4,3-d]pyrimidin-4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile

8. 2-piperazineacetonitrile, 4-(7-(3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl)-2-(((2r,7as)-2-fluorotetrahydro-1h-pyrrolizin-7a(5h)-yl)methoxy)-7,8-dihydro-5h-pyrano(4,3-d)pyrimidin-4-yl)-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2s)-

9. 2-piperazineacetonitrile, 4-[(7s)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2r,7as)-2-fluorotetrahydro-1h-pyrrolizin-7a(5h)-yl]methoxy]-7,8-dihydro-5h-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2s)-

10. 2914919-85-8

2.4 Create Date
2023-03-21
3 Chemical and Physical Properties
Molecular Weight 679.7 g/mol
Molecular Formula C32H35F6N7O3
XLogP33.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count15
Rotatable Bond Count7
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area121
Heavy Atom Count48
Formal Charge0
Complexity1250
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1